The effect of robenacoxib on the concentration of C-reactive protein in synovial fluid from dogs with osteoarthritis

被引:0
作者
David Bennett
Peter David Eckersall
Mary Waterston
Veronica Marchetti
Alessandra Rota
Eilidh McCulloch
Silvia Sbrana
机构
[1] Veterinary and Life Sciences,School of Veterinary Medicine, College of Medical
[2] University of Glasgow,Institute of Infection, Immunity & Inflammation
[3] College of Medical,Department of Veterinary Clinics, Faculty of Veterinary Medicine
[4] Veterinary and Life Sciences,ReactivLab Ltd
[5] University of Glasgow,undefined
[6] University of Pisa,undefined
[7] Garscube Estate,undefined
来源
BMC Veterinary Research | / 9卷
关键词
Stifle; Osteoarthritis; Cruciate disease; C-reactive protein; Synovial fluid; Robenacoxib;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 329 条
[1]  
Giraudel J(2009)Differential inhibition of cyclooxygenase isoenzymes in the cat by the NSAID robenacoxib J Vet Pharmacol Therapeut 32 31-40
[2]  
Toutain P(2010)In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: A comparative study Res Vet Sci 88 497-506
[3]  
King J(2010)Population pharmacokinetic analysis of blood and joint synovial fluid concentrations of robenacoxib from healthy dogs and dogs with osteoarthritis Pharm Res 27 2633-2645
[4]  
Lees P(2007)Combining enzyme specificity and tissue selectivity of cyclooxygenase inhibitors: towards better tolerability? Rheumatology 46 911-919
[5]  
King J(2004)Current research on acute phase proteins in veterinary diagnosis: an overview Vet J 168 28-40
[6]  
Rudaz C(2004)Application of acute phase protein measurement in veterinary clinical chemistry Vet Res 35 163-187
[7]  
Borer L(2005)Acute phase proteins in dogs and cats: current knowledge and future perspectives Vet Clin Pathol 34 85-99
[8]  
Jung M(2010)Acute phase proteins: biomarkers of infection and inflammation in veterinary medicine Vet J 185 23-27
[9]  
Seewald W(2008)Serum amyloid A-induced IL-6 production by rheumatoid synoviocytes FEBS Lett 582 579-585
[10]  
Lees P(2007)Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis Rheumatol Int 27 793-806